Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evogene Ltd (NYSE:EVGN)

6.89
Delayed Data
As of May 27
 +0.01 / +0.15%
Today’s Change
5.93
Today|||52-Week Range
10.18
-14.41%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close6.88
Today’s open6.86
Day’s range6.75 - 6.89
Volume4,029
Average volume (3 months)9,977
Market cap$180.4M
Dividend yield--
Data as of 4:01pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-17.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-23.31%
P/E ratio--
Price/Sales18.24
Price/Book1.74

Competitors

 Today’s
change
Today’s
% change
ENZYEnzymotec Ltd+0.01+0.11%
CYTRCytRx Corp+0.03+1.09%
OSIROsiris Therapeutics ...+0.08+1.43%
AXSMAxsome Therapeutics ...-0.75-8.55%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 17, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$11.1M
Annual profit (last year)-$17.2M
Net profit margin-154.67%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Financial Officer
Eyal Leibovitz
Corporate headquarters
Rehovot, Tel Aviv

Forecasts

Partner Offers

Search for Jobs